リキッドバイオプシーの世界市場 2023-2027Global Liquid Biopsy Market 2023-2027 リキッドバイオプシーの世界市場 2023-2027 リキッドバイオプシー市場は2022-2027年に21億6839万米ドル成長し、予測期間中のCAGRは19.54%で加速すると予測される。当レポートでは、リキッドバイオプシー市場の全... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリーリキッドバイオプシーの世界市場 2023-2027リキッドバイオプシー市場は2022-2027年に21億6839万米ドル成長し、予測期間中のCAGRは19.54%で加速すると予測される。当レポートでは、リキッドバイオプシー市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題に加え、約25のベンダーを網羅したベンダー分析を掲載しています。 現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、がん罹患率の増加、がん治療における個別化医療への注目の高まり、リキッドバイオプシー技術の進歩によって牽引されています。 Technavioのリキッドバイオプシー市場は以下のように区分される: 用途別 - がんアプリケーション - 非がん用途 技術別 - CTCおよびctDNA - エクソソームとRNA 地域別 - 北米 - ヨーロッパ - アジア - その他の地域(ROW) 本調査では、今後数年間のリキッドバイオプシー市場の成長を促進する主な理由の一つとして、リキッドバイオプシーへの資金/投資の増加を挙げている。また、学術機関、産業界、M&A間の戦略的提携やリキッドバイオプシーの新たな応用が市場の大きな需要につながる。 リキッドバイオプシー市場に関するレポートは以下の分野をカバーしています: - リキッド生検市場の規模 - リキッド生検市場予測 - リキッドバイオプシー市場の業界分析 本レポートでは、リキッドバイオプシー市場の主要ベンダーの詳細な分析を掲載しています。Menarini Industrie Farmaceutiche Riunite Srl、ANGLE Plc、Bio Rad Laboratories Inc.、Bio Techne Corp.、Biocept Inc.、Biodesix Inc.、CellMax Inc.、CIRCULOGENE、Exact Sciences Corp.、F. Hoffmann La Roche Ltd.、Guardant Health Inc.、Illumina Inc.、Inivata Ltd.、MDXHEALTH SA、Mesa Laboratories Inc.、Myriad Genetics Inc.、Novogene Co.Ltd.、OncoCyte Corp.、QIAGEN NV、SAGA Diagnostics AB。また、リキッドバイオプシー市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものである。 本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/liquid-biopsy-market-industry-size-analysis をご覧ください。 当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。 目次• 1 Executive Summaryo 1.1 Market overview o Exhibit 01: Executive Summary - Chart on Market Overview o Exhibit 02: Executive Summary - Data Table on Market Overview o Exhibit 03: Executive Summary - Chart on Global Market Characteristics o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape o Exhibit 05: Executive Summary - Chart on Market Segmentation by Application o Exhibit 06: Executive Summary - Chart on Market Segmentation by Technology o Exhibit 07: Executive Summary - Chart on Incremental Growth o Exhibit 08: Executive Summary - Data Table on Incremental Growth o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning • 2 Market Landscape o 2.1 Market ecosystem o Exhibit 10: Parent market o Exhibit 11: Market Characteristics • 3 Market Sizing o 3.1 Market definition o Exhibit 12: Offerings of vendors included in the market definition o 3.2 Market segment analysis o Exhibit 13: Market segments o 3.3 Market size 2022 o 3.4 Market outlook: Forecast for 2022-2027 o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million) o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million) o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%) o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%) • 4 Historic Market Size o 4.1 Global liquid biopsy market 2017 - 2021 o Exhibit 18: Historic Market Size - Data Table on global liquid biopsy market 2017 - 2021 ($ million) o 4.2 Application Segment Analysis 2017 - 2021 o Exhibit 19: Historic Market Size - Application Segment 2017 - 2021 ($ million) o 4.3 Technology Segment Analysis 2017 - 2021 o Exhibit 20: Historic Market Size - Technology Segment 2017 - 2021 ($ million) o 4.4 Geography Segment Analysis 2017 - 2021 o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million) o 4.5 Country Segment Analysis 2017 - 2021 o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million) • 5 Five Forces Analysis o 5.1 Five forces summary o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027 o 5.2 Bargaining power of buyers o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027 o 5.3 Bargaining power of suppliers o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027 o 5.4 Threat of new entrants o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027 o 5.5 Threat of substitutes o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027 o 5.6 Threat of rivalry o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027 o 5.7 Market condition o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027 • 6 Market Segmentation by Application o 6.1 Market segments o Exhibit 30: Chart on Application - Market share 2022-2027 (%) o Exhibit 31: Data Table on Application - Market share 2022-2027 (%) o 6.2 Comparison by Application o Exhibit 32: Chart on Comparison by Application o Exhibit 33: Data Table on Comparison by Application o 6.3 Cancer applications - Market size and forecast 2022-2027 o Exhibit 34: Chart on Cancer applications - Market size and forecast 2022-2027 ($ million) o Exhibit 35: Data Table on Cancer applications - Market size and forecast 2022-2027 ($ million) o Exhibit 36: Chart on Cancer applications - Year-over-year growth 2022-2027 (%) o Exhibit 37: Data Table on Cancer applications - Year-over-year growth 2022-2027 (%) o 6.4 Non-cancer applications - Market size and forecast 2022-2027 o Exhibit 38: Chart on Non-cancer applications - Market size and forecast 2022-2027 ($ million) o Exhibit 39: Data Table on Non-cancer applications - Market size and forecast 2022-2027 ($ million) o Exhibit 40: Chart on Non-cancer applications - Year-over-year growth 2022-2027 (%) o Exhibit 41: Data Table on Non-cancer applications - Year-over-year growth 2022-2027 (%) o 6.5 Market opportunity by Application o Exhibit 42: Market opportunity by Application ($ million) o Exhibit 43: Data Table on Market opportunity by Application ($ million) • 7 Market Segmentation by Technology o 7.1 Market segments o Exhibit 44: Chart on Technology - Market share 2022-2027 (%) o Exhibit 45: Data Table on Technology - Market share 2022-2027 (%) o 7.2 Comparison by Technology o Exhibit 46: Chart on Comparison by Technology o Exhibit 47: Data Table on Comparison by Technology o 7.3 CTC and ctDNA - Market size and forecast 2022-2027 o Exhibit 48: Chart on CTC and ctDNA - Market size and forecast 2022-2027 ($ million) o Exhibit 49: Data Table on CTC and ctDNA - Market size and forecast 2022-2027 ($ million) o Exhibit 50: Chart on CTC and ctDNA - Year-over-year growth 2022-2027 (%) o Exhibit 51: Data Table on CTC and ctDNA - Year-over-year growth 2022-2027 (%) o 7.4 Exosome and RNA - Market size and forecast 2022-2027 o Exhibit 52: Chart on Exosome and RNA - Market size and forecast 2022-2027 ($ million) o Exhibit 53: Data Table on Exosome and RNA - Market size and forecast 2022-2027 ($ million) o Exhibit 54: Chart on Exosome and RNA - Year-over-year growth 2022-2027 (%) o Exhibit 55: Data Table on Exosome and RNA - Year-over-year growth 2022-2027 (%) o 7.5 Market opportunity by Technology o Exhibit 56: Market opportunity by Technology ($ million) o Exhibit 57: Data Table on Market opportunity by Technology ($ million) • 8 Customer Landscape o 8.1 Customer landscape overview o Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria • 9 Geographic Landscape o 9.1 Geographic segmentation o Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%) o Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%) o 9.2 Geographic comparison o Exhibit 61: Chart on Geographic comparison o Exhibit 62: Data Table on Geographic comparison o 9.3 North America - Market size and forecast 2022-2027 o Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million) o Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million) o Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%) o Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%) o 9.4 Europe - Market size and forecast 2022-2027 o Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million) o Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million) o Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%) o Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%) o 9.5 Asia - Market size and forecast 2022-2027 o Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million) o Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million) o Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%) o Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%) o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027 o Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million) o Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million) o Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) o Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) o 9.7 US - Market size and forecast 2022-2027 o Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million) o Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million) o Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%) o Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%) o 9.8 Canada - Market size and forecast 2022-2027 o Exhibit 83: Chart on Canada - Market size and forecast 2022-2027 ($ million) o Exhibit 84: Data Table on Canada - Market size and forecast 2022-2027 ($ million) o Exhibit 85: Chart on Canada - Year-over-year growth 2022-2027 (%) o Exhibit 86: Data Table on Canada - Year-over-year growth 2022-2027 (%) o 9.9 Germany - Market size and forecast 2022-2027 o Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million) o Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million) o Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%) o Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%) o 9.10 UK - Market size and forecast 2022-2027 o Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million) o Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million) o Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%) o Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%) o 9.11 Japan - Market size and forecast 2022-2027 o Exhibit 95: Chart on Japan - Market size and forecast 2022-2027 ($ million) o Exhibit 96: Data Table on Japan - Market size and forecast 2022-2027 ($ million) o Exhibit 97: Chart on Japan - Year-over-year growth 2022-2027 (%) o Exhibit 98: Data Table on Japan - Year-over-year growth 2022-2027 (%) o 9.12 Market opportunity By Geographical Landscape o Exhibit 99: Market opportunity By Geographical Landscape ($ million) o Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million) • 10 Drivers, Challenges, and Trends o 10.1 Market drivers o 10.2 Market challenges o 10.3 Impact of drivers and challenges o Exhibit 101: Impact of drivers and challenges in 2022 and 2027 o 10.4 Market trends • 11 Vendor Landscape o 11.1 Overview o 11.2 Vendor landscape o Exhibit 102: Overview on Criticality of inputs and Factors of differentiation o 11.3 Landscape disruption o Exhibit 103: Overview on factors of disruption o 11.4 Industry risks o Exhibit 104: Impact of key risks on business • 12 Vendor Analysis o 12.1 Vendors covered o Exhibit 105: Vendors covered o 12.2 Market positioning of vendors o Exhibit 106: Matrix on vendor position and classification o 12.3 A. Menarini Industrie Farmaceutiche Riunite Srl o Exhibit 107: A. Menarini Industrie Farmaceutiche Riunite Srl - Overview o Exhibit 108: A. Menarini Industrie Farmaceutiche Riunite Srl - Product / Service o Exhibit 109: A. Menarini Industrie Farmaceutiche Riunite Srl - Key offerings o 12.4 ANGLE Plc o Exhibit 110: ANGLE Plc - Overview o Exhibit 111: ANGLE Plc - Product / Service o Exhibit 112: ANGLE Plc - Key offerings o 12.5 Bio Techne Corp. o Exhibit 113: Bio Techne Corp. - Overview o Exhibit 114: Bio Techne Corp. - Business segments o Exhibit 115: Bio Techne Corp. - Key news o Exhibit 116: Bio Techne Corp. - Key offerings o Exhibit 117: Bio Techne Corp. - Segment focus o 12.6 Biocept Inc. o Exhibit 118: Biocept Inc. - Overview o Exhibit 119: Biocept Inc. - Product / Service o Exhibit 120: Biocept Inc. - Key offerings o 12.7 Biodesix Inc. o Exhibit 121: Biodesix Inc. - Overview o Exhibit 122: Biodesix Inc. - Product / Service o Exhibit 123: Biodesix Inc. - Key offerings o 12.8 CellMax Inc. o Exhibit 124: CellMax Inc. - Overview o Exhibit 125: CellMax Inc. - Product / Service o Exhibit 126: CellMax Inc. - Key offerings o 12.9 CIRCULOGENE o Exhibit 127: CIRCULOGENE - Overview o Exhibit 128: CIRCULOGENE - Product / Service o Exhibit 129: CIRCULOGENE - Key offerings o 12.10 Exact Sciences Corp. o Exhibit 130: Exact Sciences Corp. - Overview o Exhibit 131: Exact Sciences Corp. - Product / Service o Exhibit 132: Exact Sciences Corp. - Key offerings o 12.11 F. Hoffmann La Roche Ltd. o Exhibit 133: F. Hoffmann La Roche Ltd. - Overview o Exhibit 134: F. Hoffmann La Roche Ltd. - Business segments o Exhibit 135: F. Hoffmann La Roche Ltd. - Key news o Exhibit 136: F. Hoffmann La Roche Ltd. - Key offerings o Exhibit 137: F. Hoffmann La Roche Ltd. - Segment focus o 12.12 Guardant Health Inc. o Exhibit 138: Guardant Health Inc. - Overview o Exhibit 139: Guardant Health Inc. - Product / Service o Exhibit 140: Guardant Health Inc. - Key news o Exhibit 141: Guardant Health Inc. - Key offerings o 12.13 Illumina Inc. o Exhibit 142: Illumina Inc. - Overview o Exhibit 143: Illumina Inc. - Business segments o Exhibit 144: Illumina Inc. - Key news o Exhibit 145: Illumina Inc. - Key offerings o Exhibit 146: Illumina Inc. - Segment focus o 12.14 MDXHEALTH SA o Exhibit 147: MDXHEALTH SA - Overview o Exhibit 148: MDXHEALTH SA - Product / Service o Exhibit 149: MDXHEALTH SA - Key offerings o 12.15 Myriad Genetics Inc. o Exhibit 150: Myriad Genetics Inc. - Overview o Exhibit 151: Myriad Genetics Inc. - Product / Service o Exhibit 152: Myriad Genetics Inc. - Key offerings o 12.16 QIAGEN NV o Exhibit 153: QIAGEN NV - Overview o Exhibit 154: QIAGEN NV - Product / Service o Exhibit 155: QIAGEN NV - Key news o Exhibit 156: QIAGEN NV - Key offerings o 12.17 SAGA Diagnostics AB o Exhibit 157: SAGA Diagnostics AB - Overview o Exhibit 158: SAGA Diagnostics AB - Product / Service o Exhibit 159: SAGA Diagnostics AB - Key offerings • 13 Appendix o 13.1 Scope of the report o 13.2 Inclusions and exclusions checklist o Exhibit 160: Inclusions checklist o Exhibit 161: Exclusions checklist o 13.3 Currency conversion rates for US$ o Exhibit 162: Currency conversion rates for US$ o 13.4 Research methodology o Exhibit 163: Research methodology o Exhibit 164: Validation techniques employed for market sizing o Exhibit 165: Information sources o 13.5 List of abbreviations o Exhibit 166: List of abbreviations Exhibits: Exhibits1: Executive Summary - Chart on Market Overview Exhibits2: Executive Summary - Data Table on Market Overview Exhibits3: Executive Summary - Chart on Global Market Characteristics Exhibits4: Executive Summary - Chart on Market By Geographical Landscape Exhibits5: Executive Summary - Chart on Market Segmentation by Application Exhibits6: Executive Summary - Chart on Market Segmentation by Technology Exhibits7: Executive Summary - Chart on Incremental Growth Exhibits8: Executive Summary - Data Table on Incremental Growth Exhibits9: Executive Summary - Chart on Vendor Market Positioning Exhibits10: Parent market Exhibits11: Market Characteristics Exhibits12: Offerings of vendors included in the market definition Exhibits13: Market segments Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million) Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million) Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%) Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%) Exhibits18: Historic Market Size - Data Table on global liquid biopsy market 2017 - 2021 ($ million) Exhibits19: Historic Market Size - Application Segment 2017 - 2021 ($ million) Exhibits20: Historic Market Size - Technology Segment 2017 - 2021 ($ million) Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million) Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million) Exhibits23: Five forces analysis - Comparison between 2022 and 2027 Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027 Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027 Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027 Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027 Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027 Exhibits29: Chart on Market condition - Five forces 2022 and 2027 Exhibits30: Chart on Application - Market share 2022-2027 (%) Exhibits31: Data Table on Application - Market share 2022-2027 (%) Exhibits32: Chart on Comparison by Application Exhibits33: Data Table on Comparison by Application Exhibits34: Chart on Cancer applications - Market size and forecast 2022-2027 ($ million) Exhibits35: Data Table on Cancer applications - Market size and forecast 2022-2027 ($ million) Exhibits36: Chart on Cancer applications - Year-over-year growth 2022-2027 (%) Exhibits37: Data Table on Cancer applications - Year-over-year growth 2022-2027 (%) Exhibits38: Chart on Non-cancer applications - Market size and forecast 2022-2027 ($ million) Exhibits39: Data Table on Non-cancer applications - Market size and forecast 2022-2027 ($ million) Exhibits40: Chart on Non-cancer applications - Year-over-year growth 2022-2027 (%) Exhibits41: Data Table on Non-cancer applications - Year-over-year growth 2022-2027 (%) Exhibits42: Market opportunity by Application ($ million) Exhibits43: Data Table on Market opportunity by Application ($ million) Exhibits44: Chart on Technology - Market share 2022-2027 (%) Exhibits45: Data Table on Technology - Market share 2022-2027 (%) Exhibits46: Chart on Comparison by Technology Exhibits47: Data Table on Comparison by Technology Exhibits48: Chart on CTC and ctDNA - Market size and forecast 2022-2027 ($ million) Exhibits49: Data Table on CTC and ctDNA - Market size and forecast 2022-2027 ($ million) Exhibits50: Chart on CTC and ctDNA - Year-over-year growth 2022-2027 (%) Exhibits51: Data Table on CTC and ctDNA - Year-over-year growth 2022-2027 (%) Exhibits52: Chart on Exosome and RNA - Market size and forecast 2022-2027 ($ million) Exhibits53: Data Table on Exosome and RNA - Market size and forecast 2022-2027 ($ million) Exhibits54: Chart on Exosome and RNA - Year-over-year growth 2022-2027 (%) Exhibits55: Data Table on Exosome and RNA - Year-over-year growth 2022-2027 (%) Exhibits56: Market opportunity by Technology ($ million) Exhibits57: Data Table on Market opportunity by Technology ($ million) Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria Exhibits59: Chart on Market share By Geographical Landscape 2022-2027 (%) Exhibits60: Data Table on Market share By Geographical Landscape 2022-2027 (%) Exhibits61: Chart on Geographic comparison Exhibits62: Data Table on Geographic comparison Exhibits63: Chart on North America - Market size and forecast 2022-2027 ($ million) Exhibits64: Data Table on North America - Market size and forecast 2022-2027 ($ million) Exhibits65: Chart on North America - Year-over-year growth 2022-2027 (%) Exhibits66: Data Table on North America - Year-over-year growth 2022-2027 (%) Exhibits67: Chart on Europe - Market size and forecast 2022-2027 ($ million) Exhibits68: Data Table on Europe - Market size and forecast 2022-2027 ($ million) Exhibits69: Chart on Europe - Year-over-year growth 2022-2027 (%) Exhibits70: Data Table on Europe - Year-over-year growth 2022-2027 (%) Exhibits71: Chart on Asia - Market size and forecast 2022-2027 ($ million) Exhibits72: Data Table on Asia - Market size and forecast 2022-2027 ($ million) Exhibits73: Chart on Asia - Year-over-year growth 2022-2027 (%) Exhibits74: Data Table on Asia - Year-over-year growth 2022-2027 (%) Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million) Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million) Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) Exhibits79: Chart on US - Market size and forecast 2022-2027 ($ million) Exhibits80: Data Table on US - Market size and forecast 2022-2027 ($ million) Exhibits81: Chart on US - Year-over-year growth 2022-2027 (%) Exhibits82: Data Table on US - Year-over-year growth 2022-2027 (%) Exhibits83: Chart on Canada - Market size and forecast 2022-2027 ($ million) Exhibits84: Data Table on Canada - Market size and forecast 2022-2027 ($ million) Exhibits85: Chart on Canada - Year-over-year growth 2022-2027 (%) Exhibits86: Data Table on Canada - Year-over-year growth 2022-2027 (%) Exhibits87: Chart on Germany - Market size and forecast 2022-2027 ($ million) Exhibits88: Data Table on Germany - Market size and forecast 2022-2027 ($ million) Exhibits89: Chart on Germany - Year-over-year growth 2022-2027 (%) Exhibits90: Data Table on Germany - Year-over-year growth 2022-2027 (%) Exhibits91: Chart on UK - Market size and forecast 2022-2027 ($ million) Exhibits92: Data Table on UK - Market size and forecast 2022-2027 ($ million) Exhibits93: Chart on UK - Year-over-year growth 2022-2027 (%) Exhibits94: Data Table on UK - Year-over-year growth 2022-2027 (%) Exhibits95: Chart on Japan - Market size and forecast 2022-2027 ($ million) Exhibits96: Data Table on Japan - Market size and forecast 2022-2027 ($ million) Exhibits97: Chart on Japan - Year-over-year growth 2022-2027 (%) Exhibits98: Data Table on Japan - Year-over-year growth 2022-2027 (%) Exhibits99: Market opportunity By Geographical Landscape ($ million) Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ million) Exhibits101: Impact of drivers and challenges in 2022 and 2027 Exhibits102: Overview on Criticality of inputs and Factors of differentiation Exhibits103: Overview on factors of disruption Exhibits104: Impact of key risks on business Exhibits105: Vendors covered Exhibits106: Matrix on vendor position and classification Exhibits107: A. Menarini Industrie Farmaceutiche Riunite Srl - Overview Exhibits108: A. Menarini Industrie Farmaceutiche Riunite Srl - Product / Service Exhibits109: A. Menarini Industrie Farmaceutiche Riunite Srl - Key offerings Exhibits110: ANGLE Plc - Overview Exhibits111: ANGLE Plc - Product / Service Exhibits112: ANGLE Plc - Key offerings Exhibits113: Bio Techne Corp. - Overview Exhibits114: Bio Techne Corp. - Business segments Exhibits115: Bio Techne Corp. - Key news Exhibits116: Bio Techne Corp. - Key offerings Exhibits117: Bio Techne Corp. - Segment focus Exhibits118: Biocept Inc. - Overview Exhibits119: Biocept Inc. - Product / Service Exhibits120: Biocept Inc. - Key offerings Exhibits121: Biodesix Inc. - Overview Exhibits122: Biodesix Inc. - Product / Service Exhibits123: Biodesix Inc. - Key offerings Exhibits124: CellMax Inc. - Overview Exhibits125: CellMax Inc. - Product / Service Exhibits126: CellMax Inc. - Key offerings Exhibits127: CIRCULOGENE - Overview Exhibits128: CIRCULOGENE - Product / Service Exhibits129: CIRCULOGENE - Key offerings Exhibits130: Exact Sciences Corp. - Overview Exhibits131: Exact Sciences Corp. - Product / Service Exhibits132: Exact Sciences Corp. - Key offerings Exhibits133: F. Hoffmann La Roche Ltd. - Overview Exhibits134: F. Hoffmann La Roche Ltd. - Business segments Exhibits135: F. Hoffmann La Roche Ltd. - Key news Exhibits136: F. Hoffmann La Roche Ltd. - Key offerings Exhibits137: F. Hoffmann La Roche Ltd. - Segment focus Exhibits138: Guardant Health Inc. - Overview Exhibits139: Guardant Health Inc. - Product / Service Exhibits140: Guardant Health Inc. - Key news Exhibits141: Guardant Health Inc. - Key offerings Exhibits142: Illumina Inc. - Overview Exhibits143: Illumina Inc. - Business segments Exhibits144: Illumina Inc. - Key news Exhibits145: Illumina Inc. - Key offerings Exhibits146: Illumina Inc. - Segment focus Exhibits147: MDXHEALTH SA - Overview Exhibits148: MDXHEALTH SA - Product / Service Exhibits149: MDXHEALTH SA - Key offerings Exhibits150: Myriad Genetics Inc. - Overview Exhibits151: Myriad Genetics Inc. - Product / Service Exhibits152: Myriad Genetics Inc. - Key offerings Exhibits153: QIAGEN NV - Overview Exhibits154: QIAGEN NV - Product / Service Exhibits155: QIAGEN NV - Key news Exhibits156: QIAGEN NV - Key offerings Exhibits157: SAGA Diagnostics AB - Overview Exhibits158: SAGA Diagnostics AB - Product / Service Exhibits159: SAGA Diagnostics AB - Key offerings Exhibits160: Inclusions checklist Exhibits161: Exclusions checklist Exhibits162: Currency conversion rates for US$ Exhibits163: Research methodology Exhibits164: Validation techniques employed for market sizing Exhibits165: Information sources Exhibits166: List of abbreviations
SummaryGlobal Liquid Biopsy Market 2023-2027 Table of Contents• 1 Executive Summaryo 1.1 Market overview o Exhibit 01: Executive Summary - Chart on Market Overview o Exhibit 02: Executive Summary - Data Table on Market Overview o Exhibit 03: Executive Summary - Chart on Global Market Characteristics o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape o Exhibit 05: Executive Summary - Chart on Market Segmentation by Application o Exhibit 06: Executive Summary - Chart on Market Segmentation by Technology o Exhibit 07: Executive Summary - Chart on Incremental Growth o Exhibit 08: Executive Summary - Data Table on Incremental Growth o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning • 2 Market Landscape o 2.1 Market ecosystem o Exhibit 10: Parent market o Exhibit 11: Market Characteristics • 3 Market Sizing o 3.1 Market definition o Exhibit 12: Offerings of vendors included in the market definition o 3.2 Market segment analysis o Exhibit 13: Market segments o 3.3 Market size 2022 o 3.4 Market outlook: Forecast for 2022-2027 o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million) o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million) o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%) o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%) • 4 Historic Market Size o 4.1 Global liquid biopsy market 2017 - 2021 o Exhibit 18: Historic Market Size - Data Table on global liquid biopsy market 2017 - 2021 ($ million) o 4.2 Application Segment Analysis 2017 - 2021 o Exhibit 19: Historic Market Size - Application Segment 2017 - 2021 ($ million) o 4.3 Technology Segment Analysis 2017 - 2021 o Exhibit 20: Historic Market Size - Technology Segment 2017 - 2021 ($ million) o 4.4 Geography Segment Analysis 2017 - 2021 o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million) o 4.5 Country Segment Analysis 2017 - 2021 o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million) • 5 Five Forces Analysis o 5.1 Five forces summary o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027 o 5.2 Bargaining power of buyers o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027 o 5.3 Bargaining power of suppliers o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027 o 5.4 Threat of new entrants o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027 o 5.5 Threat of substitutes o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027 o 5.6 Threat of rivalry o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027 o 5.7 Market condition o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027 • 6 Market Segmentation by Application o 6.1 Market segments o Exhibit 30: Chart on Application - Market share 2022-2027 (%) o Exhibit 31: Data Table on Application - Market share 2022-2027 (%) o 6.2 Comparison by Application o Exhibit 32: Chart on Comparison by Application o Exhibit 33: Data Table on Comparison by Application o 6.3 Cancer applications - Market size and forecast 2022-2027 o Exhibit 34: Chart on Cancer applications - Market size and forecast 2022-2027 ($ million) o Exhibit 35: Data Table on Cancer applications - Market size and forecast 2022-2027 ($ million) o Exhibit 36: Chart on Cancer applications - Year-over-year growth 2022-2027 (%) o Exhibit 37: Data Table on Cancer applications - Year-over-year growth 2022-2027 (%) o 6.4 Non-cancer applications - Market size and forecast 2022-2027 o Exhibit 38: Chart on Non-cancer applications - Market size and forecast 2022-2027 ($ million) o Exhibit 39: Data Table on Non-cancer applications - Market size and forecast 2022-2027 ($ million) o Exhibit 40: Chart on Non-cancer applications - Year-over-year growth 2022-2027 (%) o Exhibit 41: Data Table on Non-cancer applications - Year-over-year growth 2022-2027 (%) o 6.5 Market opportunity by Application o Exhibit 42: Market opportunity by Application ($ million) o Exhibit 43: Data Table on Market opportunity by Application ($ million) • 7 Market Segmentation by Technology o 7.1 Market segments o Exhibit 44: Chart on Technology - Market share 2022-2027 (%) o Exhibit 45: Data Table on Technology - Market share 2022-2027 (%) o 7.2 Comparison by Technology o Exhibit 46: Chart on Comparison by Technology o Exhibit 47: Data Table on Comparison by Technology o 7.3 CTC and ctDNA - Market size and forecast 2022-2027 o Exhibit 48: Chart on CTC and ctDNA - Market size and forecast 2022-2027 ($ million) o Exhibit 49: Data Table on CTC and ctDNA - Market size and forecast 2022-2027 ($ million) o Exhibit 50: Chart on CTC and ctDNA - Year-over-year growth 2022-2027 (%) o Exhibit 51: Data Table on CTC and ctDNA - Year-over-year growth 2022-2027 (%) o 7.4 Exosome and RNA - Market size and forecast 2022-2027 o Exhibit 52: Chart on Exosome and RNA - Market size and forecast 2022-2027 ($ million) o Exhibit 53: Data Table on Exosome and RNA - Market size and forecast 2022-2027 ($ million) o Exhibit 54: Chart on Exosome and RNA - Year-over-year growth 2022-2027 (%) o Exhibit 55: Data Table on Exosome and RNA - Year-over-year growth 2022-2027 (%) o 7.5 Market opportunity by Technology o Exhibit 56: Market opportunity by Technology ($ million) o Exhibit 57: Data Table on Market opportunity by Technology ($ million) • 8 Customer Landscape o 8.1 Customer landscape overview o Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria • 9 Geographic Landscape o 9.1 Geographic segmentation o Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%) o Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%) o 9.2 Geographic comparison o Exhibit 61: Chart on Geographic comparison o Exhibit 62: Data Table on Geographic comparison o 9.3 North America - Market size and forecast 2022-2027 o Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million) o Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million) o Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%) o Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%) o 9.4 Europe - Market size and forecast 2022-2027 o Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million) o Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million) o Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%) o Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%) o 9.5 Asia - Market size and forecast 2022-2027 o Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million) o Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million) o Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%) o Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%) o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027 o Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million) o Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million) o Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) o Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) o 9.7 US - Market size and forecast 2022-2027 o Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million) o Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million) o Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%) o Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%) o 9.8 Canada - Market size and forecast 2022-2027 o Exhibit 83: Chart on Canada - Market size and forecast 2022-2027 ($ million) o Exhibit 84: Data Table on Canada - Market size and forecast 2022-2027 ($ million) o Exhibit 85: Chart on Canada - Year-over-year growth 2022-2027 (%) o Exhibit 86: Data Table on Canada - Year-over-year growth 2022-2027 (%) o 9.9 Germany - Market size and forecast 2022-2027 o Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million) o Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million) o Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%) o Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%) o 9.10 UK - Market size and forecast 2022-2027 o Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million) o Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million) o Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%) o Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%) o 9.11 Japan - Market size and forecast 2022-2027 o Exhibit 95: Chart on Japan - Market size and forecast 2022-2027 ($ million) o Exhibit 96: Data Table on Japan - Market size and forecast 2022-2027 ($ million) o Exhibit 97: Chart on Japan - Year-over-year growth 2022-2027 (%) o Exhibit 98: Data Table on Japan - Year-over-year growth 2022-2027 (%) o 9.12 Market opportunity By Geographical Landscape o Exhibit 99: Market opportunity By Geographical Landscape ($ million) o Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million) • 10 Drivers, Challenges, and Trends o 10.1 Market drivers o 10.2 Market challenges o 10.3 Impact of drivers and challenges o Exhibit 101: Impact of drivers and challenges in 2022 and 2027 o 10.4 Market trends • 11 Vendor Landscape o 11.1 Overview o 11.2 Vendor landscape o Exhibit 102: Overview on Criticality of inputs and Factors of differentiation o 11.3 Landscape disruption o Exhibit 103: Overview on factors of disruption o 11.4 Industry risks o Exhibit 104: Impact of key risks on business • 12 Vendor Analysis o 12.1 Vendors covered o Exhibit 105: Vendors covered o 12.2 Market positioning of vendors o Exhibit 106: Matrix on vendor position and classification o 12.3 A. Menarini Industrie Farmaceutiche Riunite Srl o Exhibit 107: A. Menarini Industrie Farmaceutiche Riunite Srl - Overview o Exhibit 108: A. Menarini Industrie Farmaceutiche Riunite Srl - Product / Service o Exhibit 109: A. Menarini Industrie Farmaceutiche Riunite Srl - Key offerings o 12.4 ANGLE Plc o Exhibit 110: ANGLE Plc - Overview o Exhibit 111: ANGLE Plc - Product / Service o Exhibit 112: ANGLE Plc - Key offerings o 12.5 Bio Techne Corp. o Exhibit 113: Bio Techne Corp. - Overview o Exhibit 114: Bio Techne Corp. - Business segments o Exhibit 115: Bio Techne Corp. - Key news o Exhibit 116: Bio Techne Corp. - Key offerings o Exhibit 117: Bio Techne Corp. - Segment focus o 12.6 Biocept Inc. o Exhibit 118: Biocept Inc. - Overview o Exhibit 119: Biocept Inc. - Product / Service o Exhibit 120: Biocept Inc. - Key offerings o 12.7 Biodesix Inc. o Exhibit 121: Biodesix Inc. - Overview o Exhibit 122: Biodesix Inc. - Product / Service o Exhibit 123: Biodesix Inc. - Key offerings o 12.8 CellMax Inc. o Exhibit 124: CellMax Inc. - Overview o Exhibit 125: CellMax Inc. - Product / Service o Exhibit 126: CellMax Inc. - Key offerings o 12.9 CIRCULOGENE o Exhibit 127: CIRCULOGENE - Overview o Exhibit 128: CIRCULOGENE - Product / Service o Exhibit 129: CIRCULOGENE - Key offerings o 12.10 Exact Sciences Corp. o Exhibit 130: Exact Sciences Corp. - Overview o Exhibit 131: Exact Sciences Corp. - Product / Service o Exhibit 132: Exact Sciences Corp. - Key offerings o 12.11 F. Hoffmann La Roche Ltd. o Exhibit 133: F. Hoffmann La Roche Ltd. - Overview o Exhibit 134: F. Hoffmann La Roche Ltd. - Business segments o Exhibit 135: F. Hoffmann La Roche Ltd. - Key news o Exhibit 136: F. Hoffmann La Roche Ltd. - Key offerings o Exhibit 137: F. Hoffmann La Roche Ltd. - Segment focus o 12.12 Guardant Health Inc. o Exhibit 138: Guardant Health Inc. - Overview o Exhibit 139: Guardant Health Inc. - Product / Service o Exhibit 140: Guardant Health Inc. - Key news o Exhibit 141: Guardant Health Inc. - Key offerings o 12.13 Illumina Inc. o Exhibit 142: Illumina Inc. - Overview o Exhibit 143: Illumina Inc. - Business segments o Exhibit 144: Illumina Inc. - Key news o Exhibit 145: Illumina Inc. - Key offerings o Exhibit 146: Illumina Inc. - Segment focus o 12.14 MDXHEALTH SA o Exhibit 147: MDXHEALTH SA - Overview o Exhibit 148: MDXHEALTH SA - Product / Service o Exhibit 149: MDXHEALTH SA - Key offerings o 12.15 Myriad Genetics Inc. o Exhibit 150: Myriad Genetics Inc. - Overview o Exhibit 151: Myriad Genetics Inc. - Product / Service o Exhibit 152: Myriad Genetics Inc. - Key offerings o 12.16 QIAGEN NV o Exhibit 153: QIAGEN NV - Overview o Exhibit 154: QIAGEN NV - Product / Service o Exhibit 155: QIAGEN NV - Key news o Exhibit 156: QIAGEN NV - Key offerings o 12.17 SAGA Diagnostics AB o Exhibit 157: SAGA Diagnostics AB - Overview o Exhibit 158: SAGA Diagnostics AB - Product / Service o Exhibit 159: SAGA Diagnostics AB - Key offerings • 13 Appendix o 13.1 Scope of the report o 13.2 Inclusions and exclusions checklist o Exhibit 160: Inclusions checklist o Exhibit 161: Exclusions checklist o 13.3 Currency conversion rates for US$ o Exhibit 162: Currency conversion rates for US$ o 13.4 Research methodology o Exhibit 163: Research methodology o Exhibit 164: Validation techniques employed for market sizing o Exhibit 165: Information sources o 13.5 List of abbreviations o Exhibit 166: List of abbreviations Exhibits: Exhibits1: Executive Summary - Chart on Market Overview Exhibits2: Executive Summary - Data Table on Market Overview Exhibits3: Executive Summary - Chart on Global Market Characteristics Exhibits4: Executive Summary - Chart on Market By Geographical Landscape Exhibits5: Executive Summary - Chart on Market Segmentation by Application Exhibits6: Executive Summary - Chart on Market Segmentation by Technology Exhibits7: Executive Summary - Chart on Incremental Growth Exhibits8: Executive Summary - Data Table on Incremental Growth Exhibits9: Executive Summary - Chart on Vendor Market Positioning Exhibits10: Parent market Exhibits11: Market Characteristics Exhibits12: Offerings of vendors included in the market definition Exhibits13: Market segments Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million) Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million) Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%) Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%) Exhibits18: Historic Market Size - Data Table on global liquid biopsy market 2017 - 2021 ($ million) Exhibits19: Historic Market Size - Application Segment 2017 - 2021 ($ million) Exhibits20: Historic Market Size - Technology Segment 2017 - 2021 ($ million) Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million) Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million) Exhibits23: Five forces analysis - Comparison between 2022 and 2027 Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027 Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027 Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027 Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027 Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027 Exhibits29: Chart on Market condition - Five forces 2022 and 2027 Exhibits30: Chart on Application - Market share 2022-2027 (%) Exhibits31: Data Table on Application - Market share 2022-2027 (%) Exhibits32: Chart on Comparison by Application Exhibits33: Data Table on Comparison by Application Exhibits34: Chart on Cancer applications - Market size and forecast 2022-2027 ($ million) Exhibits35: Data Table on Cancer applications - Market size and forecast 2022-2027 ($ million) Exhibits36: Chart on Cancer applications - Year-over-year growth 2022-2027 (%) Exhibits37: Data Table on Cancer applications - Year-over-year growth 2022-2027 (%) Exhibits38: Chart on Non-cancer applications - Market size and forecast 2022-2027 ($ million) Exhibits39: Data Table on Non-cancer applications - Market size and forecast 2022-2027 ($ million) Exhibits40: Chart on Non-cancer applications - Year-over-year growth 2022-2027 (%) Exhibits41: Data Table on Non-cancer applications - Year-over-year growth 2022-2027 (%) Exhibits42: Market opportunity by Application ($ million) Exhibits43: Data Table on Market opportunity by Application ($ million) Exhibits44: Chart on Technology - Market share 2022-2027 (%) Exhibits45: Data Table on Technology - Market share 2022-2027 (%) Exhibits46: Chart on Comparison by Technology Exhibits47: Data Table on Comparison by Technology Exhibits48: Chart on CTC and ctDNA - Market size and forecast 2022-2027 ($ million) Exhibits49: Data Table on CTC and ctDNA - Market size and forecast 2022-2027 ($ million) Exhibits50: Chart on CTC and ctDNA - Year-over-year growth 2022-2027 (%) Exhibits51: Data Table on CTC and ctDNA - Year-over-year growth 2022-2027 (%) Exhibits52: Chart on Exosome and RNA - Market size and forecast 2022-2027 ($ million) Exhibits53: Data Table on Exosome and RNA - Market size and forecast 2022-2027 ($ million) Exhibits54: Chart on Exosome and RNA - Year-over-year growth 2022-2027 (%) Exhibits55: Data Table on Exosome and RNA - Year-over-year growth 2022-2027 (%) Exhibits56: Market opportunity by Technology ($ million) Exhibits57: Data Table on Market opportunity by Technology ($ million) Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria Exhibits59: Chart on Market share By Geographical Landscape 2022-2027 (%) Exhibits60: Data Table on Market share By Geographical Landscape 2022-2027 (%) Exhibits61: Chart on Geographic comparison Exhibits62: Data Table on Geographic comparison Exhibits63: Chart on North America - Market size and forecast 2022-2027 ($ million) Exhibits64: Data Table on North America - Market size and forecast 2022-2027 ($ million) Exhibits65: Chart on North America - Year-over-year growth 2022-2027 (%) Exhibits66: Data Table on North America - Year-over-year growth 2022-2027 (%) Exhibits67: Chart on Europe - Market size and forecast 2022-2027 ($ million) Exhibits68: Data Table on Europe - Market size and forecast 2022-2027 ($ million) Exhibits69: Chart on Europe - Year-over-year growth 2022-2027 (%) Exhibits70: Data Table on Europe - Year-over-year growth 2022-2027 (%) Exhibits71: Chart on Asia - Market size and forecast 2022-2027 ($ million) Exhibits72: Data Table on Asia - Market size and forecast 2022-2027 ($ million) Exhibits73: Chart on Asia - Year-over-year growth 2022-2027 (%) Exhibits74: Data Table on Asia - Year-over-year growth 2022-2027 (%) Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million) Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million) Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) Exhibits79: Chart on US - Market size and forecast 2022-2027 ($ million) Exhibits80: Data Table on US - Market size and forecast 2022-2027 ($ million) Exhibits81: Chart on US - Year-over-year growth 2022-2027 (%) Exhibits82: Data Table on US - Year-over-year growth 2022-2027 (%) Exhibits83: Chart on Canada - Market size and forecast 2022-2027 ($ million) Exhibits84: Data Table on Canada - Market size and forecast 2022-2027 ($ million) Exhibits85: Chart on Canada - Year-over-year growth 2022-2027 (%) Exhibits86: Data Table on Canada - Year-over-year growth 2022-2027 (%) Exhibits87: Chart on Germany - Market size and forecast 2022-2027 ($ million) Exhibits88: Data Table on Germany - Market size and forecast 2022-2027 ($ million) Exhibits89: Chart on Germany - Year-over-year growth 2022-2027 (%) Exhibits90: Data Table on Germany - Year-over-year growth 2022-2027 (%) Exhibits91: Chart on UK - Market size and forecast 2022-2027 ($ million) Exhibits92: Data Table on UK - Market size and forecast 2022-2027 ($ million) Exhibits93: Chart on UK - Year-over-year growth 2022-2027 (%) Exhibits94: Data Table on UK - Year-over-year growth 2022-2027 (%) Exhibits95: Chart on Japan - Market size and forecast 2022-2027 ($ million) Exhibits96: Data Table on Japan - Market size and forecast 2022-2027 ($ million) Exhibits97: Chart on Japan - Year-over-year growth 2022-2027 (%) Exhibits98: Data Table on Japan - Year-over-year growth 2022-2027 (%) Exhibits99: Market opportunity By Geographical Landscape ($ million) Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ million) Exhibits101: Impact of drivers and challenges in 2022 and 2027 Exhibits102: Overview on Criticality of inputs and Factors of differentiation Exhibits103: Overview on factors of disruption Exhibits104: Impact of key risks on business Exhibits105: Vendors covered Exhibits106: Matrix on vendor position and classification Exhibits107: A. Menarini Industrie Farmaceutiche Riunite Srl - Overview Exhibits108: A. Menarini Industrie Farmaceutiche Riunite Srl - Product / Service Exhibits109: A. Menarini Industrie Farmaceutiche Riunite Srl - Key offerings Exhibits110: ANGLE Plc - Overview Exhibits111: ANGLE Plc - Product / Service Exhibits112: ANGLE Plc - Key offerings Exhibits113: Bio Techne Corp. - Overview Exhibits114: Bio Techne Corp. - Business segments Exhibits115: Bio Techne Corp. - Key news Exhibits116: Bio Techne Corp. - Key offerings Exhibits117: Bio Techne Corp. - Segment focus Exhibits118: Biocept Inc. - Overview Exhibits119: Biocept Inc. - Product / Service Exhibits120: Biocept Inc. - Key offerings Exhibits121: Biodesix Inc. - Overview Exhibits122: Biodesix Inc. - Product / Service Exhibits123: Biodesix Inc. - Key offerings Exhibits124: CellMax Inc. - Overview Exhibits125: CellMax Inc. - Product / Service Exhibits126: CellMax Inc. - Key offerings Exhibits127: CIRCULOGENE - Overview Exhibits128: CIRCULOGENE - Product / Service Exhibits129: CIRCULOGENE - Key offerings Exhibits130: Exact Sciences Corp. - Overview Exhibits131: Exact Sciences Corp. - Product / Service Exhibits132: Exact Sciences Corp. - Key offerings Exhibits133: F. Hoffmann La Roche Ltd. - Overview Exhibits134: F. Hoffmann La Roche Ltd. - Business segments Exhibits135: F. Hoffmann La Roche Ltd. - Key news Exhibits136: F. Hoffmann La Roche Ltd. - Key offerings Exhibits137: F. Hoffmann La Roche Ltd. - Segment focus Exhibits138: Guardant Health Inc. - Overview Exhibits139: Guardant Health Inc. - Product / Service Exhibits140: Guardant Health Inc. - Key news Exhibits141: Guardant Health Inc. - Key offerings Exhibits142: Illumina Inc. - Overview Exhibits143: Illumina Inc. - Business segments Exhibits144: Illumina Inc. - Key news Exhibits145: Illumina Inc. - Key offerings Exhibits146: Illumina Inc. - Segment focus Exhibits147: MDXHEALTH SA - Overview Exhibits148: MDXHEALTH SA - Product / Service Exhibits149: MDXHEALTH SA - Key offerings Exhibits150: Myriad Genetics Inc. - Overview Exhibits151: Myriad Genetics Inc. - Product / Service Exhibits152: Myriad Genetics Inc. - Key offerings Exhibits153: QIAGEN NV - Overview Exhibits154: QIAGEN NV - Product / Service Exhibits155: QIAGEN NV - Key news Exhibits156: QIAGEN NV - Key offerings Exhibits157: SAGA Diagnostics AB - Overview Exhibits158: SAGA Diagnostics AB - Product / Service Exhibits159: SAGA Diagnostics AB - Key offerings Exhibits160: Inclusions checklist Exhibits161: Exclusions checklist Exhibits162: Currency conversion rates for US$ Exhibits163: Research methodology Exhibits164: Validation techniques employed for market sizing Exhibits165: Information sources Exhibits166: List of abbreviations
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療/ヘルスケア)の最新刊レポート
TechNavio社のHealth Care分野での最新刊レポート本レポートと同じKEY WORD(liquid biopsy)の最新刊レポートよくあるご質問TechNavio社はどのような調査会社ですか?テクナビオ(TechNavio)は英国ロンドンに本社をおく幅広い市場を調査対象とする調査会社インフィニティリサーチ社(Infiniti Research)の調査レポート出版部門です。データリソースはT... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/12/06 10:26 151.06 円 160.23 円 195.43 円 |